Preconditioning to improve myocardial protection.
Major advances in the composition and delivery of cardioplegia have helped to reduce the morbidity and mortality associated with coronary bypass surgery. The discovery of the preconditioning response should facilitate the development of more powerful myocardial protective agents. These new agents may act to directly stimulate the preconditioning response or may act in a supplementary fashion to either augment the response or provide protection from alternate pathways. As new techniques of myocardial protection continue to be developed, the risk-to-benefit ratio of coronary bypass surgery will continue to improve. As a result of these improvements, surgeons will be able to offer surgery to an increasingly high risk patient population without increasing the morbidity or mortality currently associated with coronary bypass.
Centre for Cardiovascular Research, University of Toronto, Ontario, Canada.
V
V
Rao
J S
JS
Ikonomidis
R D
RD
Weisel
G
G
Cohen
D000818:Animals; D002318:Cardiovascular Diseases / Q000601:surgery*; D001026:Coronary Artery Bypass / Q000379:methods*; D006324:Heart Arrest, Induced / Q000379:methods*; D006801:Humans